December 24, 2020
Teijin Pharma’s Alvesco (ciclesonide), an inhaled corticosteroid for asthma that has been seen as a potential treatment for COVID-19, failed to demonstrate efficacy in preventing the worsening of pneumonia in a Japanese clinical trial. The National Center for Global Health...read more